NCT03048864|UnknownDMC
Questionnaire for Metabolic Screening
Use of Metabolic Evaluations for Patients With Renal Calculi and the Risk of Recurrence
Loading search results
Use of Metabolic Evaluations for Patients With Renal Calculi and the Risk of Recurrence
Sponsor study identifier
observational
500
1 country
1
Study Start
October 27, 2017
Actual (reported)Primary Completion
October 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The purpose of this study is to determine if kidney stone patients who should have received metabolic tests (urine collection over 24-hours that determines the composition of urine) based on Canadian Urologic Association (CUA) guidelines did in fact receive them, and if these results were explained to them by their doctor.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 1, 2017
Actual (reported)February 9, 2017
Actual (reported)October 27, 2017
Actual (reported)October 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
October 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Metabolic Evaluation
Number of participants that did not receive metabolic evaluations based on Canadian Urologic Association (CUA) criteria
through study completion - an average of 10 months
Doctor Patient Communication
at the end of study completion - an average of 10 months
Patient Dietary/Treatment Compliance
at the end of study completion - an average of 10 months
Participants will be screened prior to extracorporeal shockwave lithotripsy and will have had at least 1 stone episode. Participants will be recruited from Saint-Luc Hospital, VGH Hospital, Glen Hospital, Dartmouth General Hospital, St.Michael's Hospital and University of Alberta Hospital.
University of British Columbia
Vancouver, British Columbia, V5Z 1M9, Canada
Nhaeem Bhojani, MD
Université de Montréal
Ben H Chew, MD
University of British Columbia
First Submitted
February 1, 2017
First Posted
February 9, 2017
Study Start
October 27, 2017
Actual (reported)Primary Completion
October 1, 2023
Estimated (date passed)Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
May 17, 2022
Record last verified: 2022-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: